Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancer

INTRODUCTION: The aim of this study was to investigate the treatment and prognosis of advanced non-small cell lung cancer (NSCLC) patients after failure of long-term treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI). MATERIAL AND METHODS: We retrospectively analyze...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arch Med Sci
Hauptverfasser: Song, Zhengbo, Zhang, Yiping
Format: Artigo
Sprache:Inglês
Veröffentlicht: Termedia Publishing House 2016
Schlagworte:
Clinical Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4754371/
https://ncbi.nlm.nih.gov/pubmed/26925125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2016.57586
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge